全球臨床試驗供應和物流市場規模、佔有率、趨勢和成長分析報告（2026-2034）

臨床試驗供應和物流市場預計將從 2025 年的 481482 億美元成長到 2034 年的 1005004 億美元，2026 年至 2034 年的複合年成長率為 8.52%。

隨著全球臨床試驗數量的增加，全球臨床試驗物資供應和物流市場正在迅速擴張。製藥和生物技術公司正投入大量資金進行研發，以開發新藥和疫苗並將其推向市場。臨床試驗材料的妥善儲存、包裝和運輸至關重要，這推動了對專業物流服務的需求。

個人化醫療和生物製藥的蓬勃發展進一步增加了臨床試驗的複雜性。對溫度敏感的藥品需要複雜的低溫運輸物流，這推動了對現代化供應鏈系統的投資。監管合規和嚴格的品質標準也是企業與專業物流供應商合作的重要因素。全球合作研究和多中心試驗的增加也為進一步發展提供了支持。

未來，即時追蹤和數據分析等數位技術將提升臨床供應鏈的透明度和效率。分散式試驗和居家參與的增加將催生新的物流需求。隨著研究活動的拓展，新興市場也預計將有重大貢獻。整體而言，該市場具有強勁的長期成長潛力。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球臨床試驗供應與物流市場：依服務分類

• 市場分析、洞察與預測
• 物流/配送
• 儲存/保留
• 包裝、標籤和遮蔽
• 製造業
• 管制藥物的採購
• 其他服務

第5章：全球臨床試驗供應與物流市場：依階段分類

• 市場分析、洞察與預測
• 第一階段
• 第二階段
• 第三階段
• 第四階段

第6章：全球臨床試驗供應與物流市場：依治療領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 心血管疾病
• 呼吸系統疾病
• 中樞神經系統和精神障礙
• 其他

第7章 全球臨床試驗供應與物流市場：依最終用途分類

• 市場分析、洞察與預測
• 製藥
• 生物製藥
• 醫療設備

第8章 全球臨床試驗供應與物流市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • UPS Healthcare
  • Piramal Pharma Solutions
  • DHL
  • Parexel International
  • Almac Group
  • Movianto
  • UDG Healthcare
  • FedEx
  • Catalent Inc

The Clinical Trial Supply & Logistics Market size is expected to reach USD 10050.04 Million in 2034 from USD 4814.82 Million (2025) growing at a CAGR of 8.52% during 2026-2034.

The Global Clinical Trial Supply & Logistics Market is expanding rapidly due to the increasing number of clinical trials worldwide. Pharmaceutical and biotechnology companies are investing heavily in research and development to launch new drugs and vaccines. Proper storage, packaging, and transportation of clinical trial materials are critical, which drives demand for specialized logistics services.

The growth of personalized medicine and biologics has further increased the complexity of clinical trials. Temperature-sensitive drugs require advanced cold chain logistics, which has boosted investment in modern supply systems. Regulatory compliance and strict quality standards also push companies to partner with professional logistics providers. The rise in global collaborations and multi-center trials supports additional growth.

In the future, digital technologies such as real-time tracking and data analytics will enhance transparency and efficiency in clinical supply chains. The increasing use of decentralized trials and home-based participation will create new logistical needs. Emerging markets are also expected to contribute significantly as research activities expand. Overall, the market has strong long-term growth potential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Other Services

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Therapeutic Area

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Others

By End Use

• Pharmaceuticals
• Biologicals
• Medical Device

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, UPS Healthcare, Piramal Pharma Solutions, DHL, Parexel International, Almac Group, Movianto, UDG Healthcare, FedEx, Catalent Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Logistics & Distribution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Storage & Retention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Packaging, Labeling, and Blinding Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Comparator Sourcing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY PHASE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Phase
• 5.2. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Phase IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. CNS and Mental Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biologicals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Medical Device Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Service
  • 8.2.2 By Phase
  • 8.2.3 By Therapeutic Area
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Service
  • 8.3.2 By Phase
  • 8.3.3 By Therapeutic Area
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Service
  • 8.4.2 By Phase
  • 8.4.3 By Therapeutic Area
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Service
  • 8.5.2 By Phase
  • 8.5.3 By Therapeutic Area
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Service
  • 8.6.2 By Phase
  • 8.6.3 By Therapeutic Area
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 UPS Healthcare
  • 10.2.3 Piramal Pharma Solutions
  • 10.2.4 DHL
  • 10.2.5 Parexel International
  • 10.2.6 Almac Group
  • 10.2.7 Movianto
  • 10.2.8 UDG Healthcare
  • 10.2.9 FedEx
  • 10.2.10 Catalent Inc